SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (2838)10/10/1997 12:43:00 PM
From: Rocketman   of 9719
 
Yeah, saw some newspaper articles this week on using "glucosamine sulfate", which they implied is a mix of glucosamine and chondroitan sulfate for relief of osteoarthritis. But, no one, such as the Arthritis Foundations, will recommend it because it isn't FDA approved. No companies will do clinical trials on it because it is a cheaply available nutritional supplement that you could never capture a market in, thus why spend millions proving something that you have no exclusivity in. Thus, the people should continue to suffer until the Pharmas find something exclusive and expensive to use. The article suggests that NIH or the foundations should be funding clinicals to prove it works. Basically, it is an argument along the lines of why marijuana will never get an FDA approval. Who wants to pay for clinicals when you could never corner the market. The current THC extract Marisol is something a pharma could maybe make money on, thus it got clinicals and approval, but plain old weed won't ever get a company spending money on it. Plus, the government is too worried that if they made it legal that it would take away too much of the graft that the current illegality of it allows to be funneled into a lot of pockets. Nothing like lots of payoffs to encourage prohibition to continue. The system is broken!

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News